UF-KURE-BCMA
/ Case Comprehensive Cancer Center, Kure Cells
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
May 29, 2026
Study to Evaluate the Safety of UF-KURE-BCMA CAR T-Cells in Advanced Myeloma
(clinicaltrials.gov)
- P1 | N=12 | Not yet recruiting | Sponsor: Kure Cells, INC
New P1 trial • Hematological Malignancies • Multiple Myeloma • Oncology
May 14, 2026
UF-KURE-BCMA CAR-T Cells in Patients With Relapsed or Refractory Multiple Myeloma
(clinicaltrials.gov)
- P1 | N=0 | Withdrawn | Sponsor: David Wald | N=12 ➔ 0 | Not yet recruiting ➔ Withdrawn
Enrollment change • Trial withdrawal • Hematological Malignancies • Multiple Myeloma • Oncology
1 to 2
Of
2
Go to page
1